Seroprevalence of infectious bovine rhinotracheitis in mithun (Bos frontalis) in India.
Seroprevalence of infectious bovine rhinotracheitis in mithun (Bos frontalis) in India.
复制标题
DOI：
10.20506/rst.23.3.1523
复制
发表时间：
2004-12
期刊：
影响因子：
--
通讯作者：
S. Rajkhowa;C. Rajkhowa;Habibur Rahman;K. Bujarbaruah
中科院分区：
文献类型：
--
作者：
S. Rajkhowa;C. Rajkhowa;Habibur Rahman;K. Bujarbaruah
印度那加兰邦密顿国家研究中心对密顿不同品系牛传染性鼻气管炎(IBR)的血清阳性率进行了初步研究，结果表明，这些密顿的IBR总患病率为19%。本文对这一初步研究的结果进行了检验。据作者所知，这是关于印度密顿IBR血清阳性率的第一份报告。阿鲁纳恰尔邦的Mithun的IBR患病率最高(38.46%)，其次是Mizoram(18.18%)和Nagaland(15.15%)。来自曼尼普尔的动物中没有一只检测出IBR抗体阳性。动物性别对IBR患病率无影响。3岁以上儿童患病率最高(27.03%)，6个月~1岁儿童患病率最低(7.69%)。密顿种公牛IBR患病率为88.9%。在本文中，作者简要讨论了野生动物和家畜在该病在密顿传播中的可能作用，反之亦然。并对密屯市IBR防控工作中可能采取的各项措施进行了调查。但需要强调的是，这项研究是初步的，作者目前正在进行进一步的研究。
A preliminary study on the seroprevalence of infectious bovine rhinotracheitis (IBR) in different strains of mithun maintained atthe National Research Centre on Mithun, Nagaland, India, revealed that the overall prevalence of IBR in these mithun was 19%. This paper examines the results of that preliminary study. To the knowledge of the authors, this is the first report on the seroprevalence of IBR in mithun in India. The highest prevalence of IBR was observed in mithun found in Arunachal Pradesh (38.46%), followed by those found in Mizoram (18.18%) and Nagaland (15.15%). None of the animals from Manipur were found to test positive for antibodies against IBR. The sex of the animal had no influence on IBR prevalence. The prevalence was found to be highest (27.03%) in mithun above three years of age and lowest (7.69%) in mithun aged between six months and one year. The prevalence of IBR was found to be 88.9% in breeding mithun bulls. In this paper, the authors briefly discuss the possible roles of feral fauna and domestic livestock in the transmission of this disease to mithun and vice versa. Various measures that may help in the prevention and control of IBR in mithun are also surveyed. However, it should be emphasised that this study is a preliminary one, and the authors are currently engaged in further research.